Evidence map›Paper›PMID 38494719›Full record

ArticleInternal medicine (Tokyo, Japan)2024

The Epidemiology of Circulating Respiratory Pathogens during the COVID-19 Pandemic.

Haruka Imai, Jun Suzuki, Shota Takahashi, Daishi Shimada, Makiko Yoshida, Shiro Endo, Mitsuo Kaku

Abstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haruka ImaiDivision of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.
Jun SuzukiDivision of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.
Shota TakahashiDepartment of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Japan.
Daishi ShimadaDivision of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.
Makiko YoshidaDivision of Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University, Japan.
Shiro EndoDivision of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.
Mitsuo KakuDivision of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective To survey the epidemiology of respiratory pathogens during the coronavirus disease 2019 (COVID-19) pandemic using multiplex polymerase chain reaction (PCR). Methods Specimens were assayed using multiplex nested PCR. Materials Specimens were obtained from outpatients who presented with symptoms of upper respiratory tract infection and asymptomatic outpatients who had contact with patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at Tohoku Medical and Pharmaceutical University Hospital in Sendai, Japan, from November 1, 2020, to May 31, 2023. The analysis included multiple specimens collected from the same patients at different time-points. Data were collected from the electronic records after testing. Results This study included 8,335 patients (4,311 men) with a median age of 59 years old, and 11,741 total specimens were collected. At least 1 positive SARS-CoV-2 result was obtained for 1,710 (14.6%) specimens. Furthermore, 15 pathogens were identified in the positive specimens, and rhinovirus/enterovirus was detected more frequently than other viruses. We identified a larger number of SARS-CoV-2-positive specimens in patients ≥10 years old. In contrast, in patients 0-9 years old, we identified a larger number of specimens positive for rhinovirus/enterovirus than for other viruses. Conclusion In this study, we examined the epidemiology of circulating respiratory pathogens during the COVID-19 pandemic era.

Indexed as

COVID-19Respiratory Tract InfectionsSARS-CoV-2AdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantInfant, NewbornJapanMaleMiddle AgedCOVID-19epidemiologymultiplex polymerase chain reaction assayrespiratory pathogensSARS-CoV-2

Identifiers

PMID38494719
PMCPMC11239251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.